Contraceptives Market
Market Insights on Contraceptives covering sales outlook, demand forecast & up-to-date key trends
Contraceptives Market by Product, Gender, End User & Region - Forecast 2022 – 2032
Contraceptives Market Outlook (2022-2032)
[200 Pages Report] The global contraceptives market is expected to reach a valuation of US$ 18 Bn in 2022. Demand for contraceptive drugs and devices is slated to surge at a 5.5% CAGR, with the total market size reaching US$ 30.8 Bn by 2032. According to a recent study by Future Market Insights (FMI), devices are leading the market in terms of product, with a share of about 58.3% in 2021.
Market Outlook:
|
Data Points |
Market Insights |
|
Contraceptives Market Base Year Value (2021) |
US$ 17.3 Bn |
|
Estimated Market Size (2022) |
US$ 18.0 Bn |
|
Projected Market Valuation (2032) |
US$ 30.8 Bn |
|
Value-based CAGR (2022-2032) |
5.5% |
|
Market Share of Top 5 Countries |
53.3% |
The market value for contraceptives was approximately 43.1% of the overall US$ 40 Bn of the global sexual wellness market in 2021.
Demand for contraceptives is increasing due to the rising need for the prevention of unplanned pregnancy. A variety of factors, including sociodemographic parameters (age, residency, religion, educational and socioeconomic position), family traits and preferences (number of surviving children, intended family size), and family planning programme exposure are expected to influence contraceptive use.
The hazards of morbidity and mortality associated with pregnancy and delivery are well known. Contraceptives have both contraceptive and non-contraceptive health advantages. Oral contraceptives, for instance, not only prevent conception but also lower the chance of ovarian and endometrial cancer, as well as ectopic pregnancies.
Let us know your requirement to get
100% FREE customization
2017-2021 Contraceptives Market Historic Outlook Vs 2022-2032 Forecast
Sales of contraceptives increased at a CAGR of 3.5% from 2017 to 2021, owing to the rising need to reduce teenage pregnancies.
Early pregnancy can also cause health problems for the new born. Babies born to adolescents are likely to be underweight before and at birth and are at higher risk of neonatal mortality.
According to the Centers for Disease Control and Prevention, mortality rates among infants born to adolescents aged 15 to 19 were greatest from 2017 to 2018, with 8.8 deaths per 1,000 live births, as compared to infants born to women aged 20 and up. Preterm birth, low birth weight, and congenital deformities contributed to these deaths.
The market is driven by various initiatives taken by governments across the globe to promote awareness and accessibility to birth control methods, or family planning. For instance, USAID (the U.S. Agency for International Development) advances and aids in family planning and reproductive health programs in approximately 40 countries across the globe.
Organizations such as the European Network, European Society of Contraception and Reproductive Health (ESC), United Nations Population Fund (UNFPA), the International Planned Parenthood Federation (IPPF), and the United States Agency for International Development (USAID) help in providing family planning guidance and adoption of WHO guidelines related to contraceptives.
According to WHO, around 842.0 million people are using contraceptive methods and 270.0 million people have an unmet need for contraception, out of 1.9 billion women of the reproductive age, globally, in 2019.
Apart from birth control, contraceptive products such as condoms can prevent the transmission of sexually transmitted infections, including HIV. For instance, according to the data provided by WHO, 37.7 million people were living with AIDS/HIV in the world in 2020. This can be reduced by using contraceptive products such as condoms.
The increasing need for contraception owing to higher awareness among the reproductive age group for birth control and family planning is expected to create opportunities for growth in the market over the forecast period.
What are the Key Opportunities for Manufacturers in the Contraceptives Market?
Sales of contraceptives are expected to rise due to the introduction of more effective male contraception products. Currently, female contraceptives are leading in the market but male contraceptives will witness high demand due to the increasing usage of male condoms.
The usage of condoms is increasing due to their dual role in both birth control and prevention of sexually transmitted diseases (STD). In addition to this, it has low to no side effects on the body.
A large number of women of reproductive age in developing countries have unmet needs, such as limited access to contraception, limited choice of methods, social and religious issues, poor quality of available services, and gender-based barriers. All these unmet needs can lead to a higher risk of unintended pregnancy.
As a result, manufacturers are aiming to expand their products and services across developing economies to improve sales.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat Factors are Restraining the Demand for Contraceptives?
Birth control drugs and devices have various side effects, such as spotting or bleeding between periods, most commonly from progestin-only pills, sore breasts, nausea, or headaches.
In rare cases, the side effects are very serious such as blood clots in the legs, heart attacks and stroke, liver disorders, and gallbladder disease. These side effects associated with the usage of contraceptives will limit sales over the forecast period.
Furthermore, lack of knowledge, misperceptions, lack of social acceptance, and exaggerated fears about the safety of contraceptive methods are major barriers to contraceptive use.
Moreover, oral contraceptives elevate the risk of heart disease. IUDs are effective contraception; however, they raise the risk of infection in some high-risk individuals. Barrier contraception is less effective than other forms of contraception, but it protects against sexually transmitted infections like HIV. Because of differences in the prevalence of the disorders implicated, the value of non-contraceptive benefits and hazards of contraceptives differs among nations.
Country-wise Insights
What is Driving the U.S. Contraceptives Market?
“Increasing Adoption of Female Condoms in the U.S. will Fuel Growth”
The U.S. dominated the North America contraceptives market, holding 92.8% of the total market share in 2021. As per the report, the trend is expected to continue over the forecast period.
The U.S. is one of the world's leading users and suppliers of contraceptives. The government has been involved in global family planning/reproductive health (FP/RH) activities for more than 50 years and is the world's largest donor in this field.
Moreover, the U.S. also increased their funding for FP/RH in the recent years. For instance, in 2020 U.S. funded approximately US$ 608.0 million for FP/RH, which includes funding for the United Nations Population Fund (UNFPA). Such initiatives are expected to bode well for the growth in the market.
Why is the Germany Contraceptives Market Considered Lucrative?
“Surging Demand for Contraceptive Devices in Germany Will Boost Growth”
Germany is set to exhibit a CAGR of nearly 5.5% in the Europe contraceptives market during the forecast period. Due to superior public health insurance, Germany is likely to be the most profitable market in the region. Birth control is covered by Germany's national health insurance for women under the age of 22.
Furthermore, contraceptive use is extremely common in the country. Due to outstanding access to online information and average availability to contraceptive supplies, Germany receives a 75.1 in the 2020 European Contraception Policy Atlas.
How is the China Contraceptives Market Faring?
“Rising Awareness Regarding Family Planning in China Will Spur Demand for Oral Contraceptives”
China accounted for about 43.4% of the East Asia contraceptives market share in 2021. Over the forecast period, demand for contraceptives is slated to grow at a 6.1% CAGR.
East & Southeast Asia and Pacific, which includes China, is expected to have the most married users (248 million), followed by Southern Asia (245.1 million), which includes India. With a rise in the number of married couples, the need for family planning comes into place.
China imported roughly 42.36 metric tonnes of hormonal contraceptive preparations in February 2022, up from just 5.28 metric tonnes the previous year. The total value of hormonal contraceptives imported in that month was 218.5 million yuan.
Better education and awareness among youth are also propelling the use of contraceptives in the country.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Category-wise Insights
Which Contraceptives Product is Driving Growth in the Market?
“Adoption of Contraceptive Devices Will Steer Sales in the Market”
By product type, the devices segment held a share of 58.3% in 2021. Over the assessment period, sales in this segment will increase at a CAGR of 5.5% through 2032.
Strong government promotions and initiatives for women's and children's health are propelling the usage of contraceptive devices. Government involvement in promoting family planning and contraception, particularly in emerging economies, is a crucial factor boosting the global contraceptives market.
Which Gender is Largely in Focus within the Contraceptives Market?
“Demand for Contraceptives Among Females Will Gain Traction”
Based on gender, the female segment accounted for about 74.9% of the total market share in 2021, and is expected to hold 74.3% in 2032. Female contraceptive methods are more popular than the male contraceptives because of their higher efficiency in preventing pregnancy.
According to American Sexual Health Association, male condoms are around 84% effective in preventing pregnancy, whereas pills are 92%-97% effective, implants are 99.9% effective, and IUDs are 99% effective.
Which Sales Channel Holds Maximum Share in the Contraceptives Market?
“Sales of Contraceptives through Retail Sales to Remain High”
In terms of sales channel, the retail sales segment held around 44.3% of the total market share in 2021. As per the report, total sales in this segment will account for nearly 44.4% of the total market share in 2032.
Contraceptives are widely sold through retail pharmacies, drug stores, and supermarkets/ hypermarkets. Integration of contraceptive delivery with other development programs, community-based distribution of contraceptives and commercial retail sales will push sales in this segment over the forecast period.
Competitive Landscape
Key players in the contraceptive market are concentrating on acquisitions and collaborations, and gaining FDA approvals as the key strategies for expanding their presence in the market.
These will support market players such as Cooper Surgical, Inc., AbbVie, and Exeltis USA, Inc. to improve their product portfolio together with market penetration. Some recent developments include:
- In December 2021, Cooper Surgical, Inc. completed the acquisition of Generate Life Sciences. This acquisition helps Cooper to improve their reproductive segment.
- In November 2020, AbbVie announced a partnership with the American College of Obstetricians and Gynaecologists, the Endometriosis Association, Healthy Women, the International Pelvic Pain Society, GE Healthcare, and the Black Women's Health Imperative to help improve the lives of the one in ten women of reproductive age in the United States who suffer from this disease.
- In July 2019, Exeltis USA, Inc. gained approval from US Food and Drug Administration (FDA) for Slynd™, which is an oral contraceptive tablet for preventing pregnancy.
Report Scope as per Contraceptives Industry Analysis
|
Attribute |
Details |
|
Forecast Period |
2017-2021 |
|
Historical Data Available for |
2022-2032 |
|
Market Analysis |
US$ Bn for Value |
|
Key Regions Covered |
North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa |
|
Key Countries Covered |
The U.S., China, Japan, Germany, Canada, the U.K., India, South Korea, Russia, Australia, BENELUX, Spain, Indonesia, France, Italy, Brazil, Thailand, Malaysia, Mexico, GCC, Argentina, South Africa, Turkey, and New Zealand |
|
Key Market Segments Covered |
Product, Gender, End User, and Region |
|
Key Companies Profiled |
|
Key Market Segments Covered in Contraceptives Industry Research
By Product:
- Drugs
- Oral Contraceptive Pills
- Injectable Contraceptives
- Topical Contraceptives
- Devices
- Condoms
- Diaphragms
- Contraceptive Sponges
- Vaginal Rings
- Cervical Cap
- Subdermal Implants
- Intra-uterine Devices
- Copper
- Hormonal
By Gender:
- Female
- Male
By End User:
- Institutional Sales
- Hospitals
- Specialty Clinics
- Retail Sales
- Retail Pharmacy
- Drug Stores
- Supermarkets/ Hypermarkets
- Online Sales
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- The Middle East and Africa (MEA)
Frequently Asked Questions
The global contraceptives market is projected to total US$ 18 Bn in 2022 and is set to expand 1.7X over the next ten years.
The contraceptives market is expected to reach US$ 30.8 Bn by 2032, with sales growing at a 5.5% CAGR.
Increasing rate of sexually transmitted diseases, the rise in the use of oral pills among teenagers, and rising government initiatives to promote maternal and child health, are some of the key trends in this market.
The U.S., China, India, Japan, and South Korea are expected to drive demand for the contraceptives industry.
North America is one of the key markets for contraceptives, with the U.S. expected to account for over 93.0% of the North American market in the year 2032.
Demand for contraceptives in Europe is expected to register growth of 5.4% over the next ten years.
The U.S., China and the U.K. are key producers of contraceptives products.
Bayer AG Pfizer Inc., Janssen Global Services, LLC, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Mylan N.V., Allergan Plc., Reckitt Benckiser Group plc, Veru Inc., Church & Dwight Co., Inc., Medisafe Distribution Inc., Cooper Surgical, Inc., Mayer Laboratories, Inc., Pfizer Inc., The Female Health Company, and Exeltis USA, Inc. are the key exporters of contraceptives market.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Value Added Insights
4.1. New Product Launches
4.2. New Technologies
4.3. Guidelines, Regulations and Reimbursement
4.4. Assessment of Unmet Needs
4.5. PESTEL Analysis
4.6. Porter’s Analysis
5. COVID-19 Crisis Analysis
5.1.1. Current COVID-19 Statistics and Probable Future Impact
5.1.2. COVID-19 and Impact Analysis
5.1.3. Revenue by Product
5.1.4. Revenue by Gender
5.1.5. Revenue by End User
5.1.6. Revenue by Region
6. Market Background
6.1. Macro-Economic Factors
6.1.1. Global GDP Outlook
6.1.2. Global Healthcare Spending Outlook
6.1.3. Global Pharmaceutical Outlook
6.2. Forecast Factors - Relevance & Impact
6.2.1. Adoption rate of Contraceptives
6.2.2. Rising Awareness Regarding Female Reproductive Health
6.2.3. Strategic Collaborations
6.2.4. Rising Reproductive Age Population
6.2.5. Rise of Healthcare Spending in Developing Economies
6.2.6. Frequency of Product Launches
6.2.7. Rise in Teenage Pregnancies
6.2.8. Growing Number of Product Manufacturers
6.3. Market Dynamics
6.3.1. Drivers
6.3.2. Restraints
6.3.3. Opportunity Analysis
7. Global Contraceptives Market Volume (Units) Analysis 2017–2021 and Forecast, 2022–2032
7.1. Historical Market Volume (Units) Analysis, 2017–2021
7.2. Current and Future Market Volume (Units) Projections, 2022–2032
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Contraceptives Market - Pricing Analysis
8.1. Regional Pricing Analysis By Product Type
8.2. Pricing Break-up
8.2.1. Manufacturer Level Pricing
8.2.2. Distributor Level Pricing
8.3. Global Average Pricing Analysis Benchmark
9. Global Contraceptives Market Demand (in Value or Size in US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032
9.1. Historical Market Value (US$ Mn) Analysis, 2017–2021
9.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Contraceptives Market Analysis 2017–2021 and Forecast 2022–2032, by Product
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) and Volume Analysis By Product, 2017–2021
10.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Product, 2022–2032
10.3.1. Drugs
10.3.1.1. Oral Contraceptive Pills
10.3.1.2. Injectable Contraceptives
10.3.1.3. Topical Contraceptives
10.3.2. Devices
10.3.2.1. Condoms
10.3.2.2. Diaphragms
10.3.2.3. Contraceptive Sponges
10.3.2.4. Vaginal Rings
10.3.2.5. Cervical Cap
10.3.2.6. Subdermal Implants
10.3.2.7. Intra-uterine Devices
10.3.2.7.1. Copper
10.3.2.7.2. Hormonal
10.4. Market Attractiveness Analysis By Product
11. Global Contraceptives Market Analysis 2017–2021 and Forecast 2022–2032, by Gender
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn), By Gender, 2017–2021
11.3. Current and Future Market Size (US$ Mn) and Forecast By Gender, 2022–2032
11.3.1. Female
11.3.2. Male
11.4. Market Attractiveness Analysis By Gender
12. Global Contraceptives Market Analysis 2017–2021 and Forecast 2022–2032, by End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn), By End User, 2017–2021
12.3. Current and Future Market Size (US$ Mn) Forecast By End User, 2022–2032
12.3.1. Institutional Sales
12.3.1.1. Hospitals
12.3.1.2. Specialty Clinics
12.3.2. Retail Sales
12.3.2.1. Retail Pharmacy
12.3.2.2. Drug Stores
12.3.2.3. Supermarkets/ Hypermarkets
12.3.3. Online Sales
12.4. Market Attractiveness Analysis By End User
13. Global Contraceptives Market Analysis 2017–2021 and Forecast 2022–2032, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2017–2021
13.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2022–2032
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. East Asia
13.3.5. South Asia
13.3.6. Oceania
13.3.7. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis By Region
14. North America Contraceptives Market Analysis 2017–2021 and Forecast 2022–2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017–2021
14.4. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022–2032
14.4.1. By Country
14.4.1.1. U.S.
14.4.1.2. Canada
14.4.2. By Product
14.4.3. By Gender
14.4.4. By End User
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product
14.5.3. By Gender
14.5.4. By End User
14.6. Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis
14.9. Country Level Analysis & Forecast
14.9.1. U.S. Contraceptives Market Analysis
14.9.1.1. .Introduction
14.9.1.2. Market Analysis and Forecast by Market Taxonomy
14.9.1.2.1. By Product
14.9.1.2.2. By Gender
14.9.1.2.3. By End User
14.9.2. Canada Contraceptives Market Analysis
14.9.2.1. Introduction
14.9.2.2. Market Analysis and Forecast by Market Taxonomy
14.9.2.2.1. By Product
14.9.2.2.2. By Gender
14.9.2.2.3. By End User
15. Latin America Contraceptives Market Analysis 2017–2021 and Forecast 2022–2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017–2021
15.4. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022–2032
15.4.1. By Country
15.4.1.1. Mexico
15.4.1.2. Brazil
15.4.1.3. Argentina
15.4.1.4. Rest of Latin America
15.4.2. By Product
15.4.3. By Gender
15.4.4. By End User
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Product
15.5.3. By Gender
15.5.4. By End User
15.6. Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis
15.9. Country Level Analysis & Forecast
15.9.1. Mexico Contraceptives Market Analysis
15.9.1.1. Introduction
15.9.1.2. Market Analysis and Forecast by Market Taxonomy
15.9.1.2.1. By Product
15.9.1.2.2. By Gender
15.9.1.2.3. By End User
15.9.2. Brazil Contraceptives Market Analysis
15.9.2.1. Introduction
15.9.2.2. Market Analysis and Forecast by Market Taxonomy
15.9.2.2.1. By Product
15.9.2.2.2. By Gender
15.9.2.2.3. By End User
15.9.3. Argentina Contraceptives Market Analysis
15.9.3.1. Introduction
15.9.3.2. Market Analysis and Forecast by Market Taxonomy
15.9.3.2.1. By Product
15.9.3.2.2. By Gender
15.9.3.2.3. By End User
16. Europe Contraceptives Market Analysis 2017–2021 and Forecast 2022–2032
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017–2021
16.4. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022–2032
16.4.1. By Country
16.4.1.1. Germany
16.4.1.2. Italy
16.4.1.3. France
16.4.1.4. U.K.
16.4.1.5. Spain
16.4.1.6. BENELUX
16.4.1.7. Nordic Countries
16.4.1.8. Russia
16.4.1.9. Rest of Europe
16.4.2. By Product
16.4.3. By Gender
16.4.4. By End User
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Product
16.5.3. By Gender
16.5.4. By End User
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
16.9. Country Level Analysis & Forecast
16.9.1. Germany Contraceptives Market Analysis
16.9.1.1. Introduction
16.9.1.2. Market Analysis and Forecast by Market Taxonomy
16.9.1.2.1. By Product
16.9.1.2.2. By Gender
16.9.1.2.3. By End User
16.9.2. Italy Contraceptives Market Analysis
16.9.2.1. Introduction
16.9.2.2. Market Analysis and Forecast by Market Taxonomy
16.9.2.2.1. By Product
16.9.2.2.2. By Gender
16.9.2.2.3. By End User
16.9.3. France Contraceptives Market Analysis
16.9.3.1. Introduction
16.9.3.2. Market Analysis and Forecast by Market Taxonomy
16.9.3.2.1. By Product
16.9.3.2.2. By Gender
16.9.3.2.3. By End User
16.9.4. U.K. Contraceptives Market Analysis
16.9.4.1. Introduction
16.9.4.2. Market Analysis and Forecast by Market Taxonomy
16.9.4.2.1. By Product
16.9.4.2.2. By Gender
16.9.4.2.3. By End User
16.9.5. Spain Contraceptives Market Analysis
16.9.5.1. Introduction
16.9.5.2. Market Analysis and Forecast by Market Taxonomy
16.9.5.2.1. By Product
16.9.5.2.2. By Gender
16.9.5.2.3. By End User
16.9.6. BENELUX Contraceptives Market Analysis
16.9.6.1. Introduction
16.9.6.2. Market Analysis and Forecast by Market Taxonomy
16.9.6.2.1. By Product
16.9.6.2.2. By Gender
16.9.6.2.3. By End User
16.9.7. Nordic Countries & Russia Contraceptives Market Analysis
16.9.7.1. Introduction
16.9.7.2. Market Analysis and Forecast by Market Taxonomy
16.9.7.2.1. By Product
16.9.7.2.2. By Gender
16.9.7.2.3. By End User
16.9.8. Russia Contraceptives Market Analysis
16.9.8.1. Introduction
16.9.8.2. Market Analysis and Forecast by Market Taxonomy
16.9.8.2.1. By Product
16.9.8.2.2. By Gender
16.9.8.2.3. By End User
17. East Asia Contraceptives Market Analysis 2017–2021 and Forecast 2022–2032
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017–2021
17.4. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022–2032
17.4.1. By Country
17.4.1.1. China
17.4.1.2. Japan
17.4.1.3. South Korea
17.4.2. By Product
17.4.3. By Gender
17.4.4. By End User
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Product
17.5.3. By Gender
17.5.4. By End User
17.6. Market Trends
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis
17.9. Country Level Analysis & Forecast
17.9.1. China Contraceptives Market Analysis
17.9.1.1. Introduction
17.9.1.2. Market Analysis and Forecast by Market Taxonomy
17.9.1.2.1. By Product
17.9.1.2.2. By Gender
17.9.1.2.3. By End User
17.9.2. Japan Contraceptives Market Analysis
17.9.2.1. Introduction
17.9.2.2. Market Analysis and Forecast by Market Taxonomy
17.9.2.2.1. By Product
17.9.2.2.2. By Gender
17.9.2.2.3. By End User
17.9.3. South Korea Contraceptives Market Analysis
17.9.3.1. Introduction
17.9.3.2. Market Analysis and Forecast by Market Taxonomy
17.9.3.2.1. By Product
17.9.3.2.2. By Gender
17.9.3.2.3. By End User
18. South Asia Contraceptives Market Analysis 2017–2021 and Forecast 2022–2032
18.1. Introduction
18.2. Pricing Analysis
18.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017–2021
18.4. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022–2032
18.4.1. By Country
18.4.1.1. India
18.4.1.2. Indonesia
18.4.1.3. Malaysia
18.4.1.4. Philippines
18.4.1.5. Thailand
18.4.1.6. Vietnam
18.4.1.7. Rest of South Asia
18.4.2. By Product
18.4.3. By Gender
18.4.4. By End User
18.5. Market Attractiveness Analysis
18.5.1. By Country
18.5.2. By Product
18.5.3. By Gender
18.5.4. By End User
18.6. Market Trends
18.7. Key Market Participants - Intensity Mapping
18.8. Drivers and Restraints - Impact Analysis
18.9. Country Level Analysis & Forecast
18.9.1. India Contraceptives Market Analysis
18.9.1.1. Introduction
18.9.1.2. Market Analysis and Forecast by Market Taxonomy
18.9.1.2.1. By Product
18.9.1.2.2. By Gender
18.9.1.2.3. By End User
18.9.2. Indonesia Contraceptives Market Analysis
18.9.2.1. Introduction
18.9.2.2. Market Analysis and Forecast by Market Taxonomy
18.9.2.2.1. By Product
18.9.2.2.2. By Gender
18.9.2.2.3. By End User
18.9.3. Malaysia Contraceptives Market Analysis
18.9.3.1. Introduction
18.9.3.2. Market Analysis and Forecast by Market Taxonomy
18.9.3.2.1. By Product
18.9.3.2.2. By Gender
18.9.3.2.3. By End User
18.9.4. Philippines Contraceptives Market Analysis
18.9.4.1. Introduction
18.9.4.2. Market Analysis and Forecast by Market Taxonomy
18.9.4.2.1. By Product
18.9.4.2.2. By Gender
18.9.4.2.3. By End User
18.9.5. Thailand Contraceptives Market Analysis
18.9.5.1. Introduction
18.9.5.2. Market Analysis and Forecast by Market Taxonomy
18.9.5.2.1. By Product
18.9.5.2.2. By Gender
18.9.5.2.3. By End User
18.9.6. Vietnam Contraceptives Market Analysis
18.9.6.1. Introduction
18.9.6.2. Market Analysis and Forecast by Market Taxonomy
18.9.6.2.1. By Product
18.9.6.2.2. By Gender
18.9.6.2.3. By End User
18.9.6.2.4.
18.9.7. Rest of South Asia Contraceptives Market Analysis
18.9.7.1. Introduction
18.9.7.2. Market Analysis and Forecast by Market Taxonomy
18.9.7.2.1. By Product
18.9.7.2.2. By Gender
18.9.7.2.3. By End User
19. Oceania Contraceptives Market 2017-2021 and Forecast 2022-2032
19.1. Introduction
19.2. Pricing Analysis
19.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017–2021
19.4. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022–2032
19.4.1. By Country
19.4.1.1. Australia
19.4.1.2. New Zealand
19.4.2. By Product
19.4.3. By Gender
19.4.4. By End User
19.5. Market Attractiveness Analysis
19.5.1. By Country
19.5.2. By Product
19.5.3. By Gender
19.5.4. By End User
19.6. Key Market Participants - Intensity Mapping
19.7. Drivers and Restraints - Impact Analysis
19.8. Country Level Analysis & Forecast
19.8.1. Australia Contraceptives Market Analysis
19.8.1.1. Introduction
19.8.1.2. Market Analysis and Forecast by Market Taxonomy
19.8.1.2.1. By Product
19.8.1.2.2. By Gender
19.8.1.2.3. By End User
19.8.2. New Zealand Contraceptives Market Analysis
19.8.2.1. Introduction
19.8.2.2. Market Analysis and Forecast by Market Taxonomy
19.8.2.2.1. By Product
19.8.2.2.2. By Gender
19.8.2.2.3. By End User
20. Middle East and Africa (MEA) Contraceptives Market Analysis 2017–2021 and Forecast 2022–2032
20.1. Introduction
20.2. Pricing Analysis
20.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017–2021
20.4. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022–2032
20.4.1. By Country
20.4.1.1. GCC Countries
20.4.1.2. Israel
20.4.1.3. Turkey
20.4.1.4. South Africa & North Africa
20.4.1.5. Rest of Middle East and Africa
20.4.2. By Product
20.4.3. By Gender
20.4.4. By End User
20.5. Market Attractiveness Analysis
20.5.1. By Country
20.5.2. By Product
20.5.3. By Gender
20.5.4. By End User
20.6. Market Trends
20.7. Key Market Participants - Intensity Mapping
20.8. Drivers and Restraints - Impact Analysis
20.9. Country Level Analysis & Forecast
20.9.1. GCC Countries Contraceptives Market Analysis
20.9.1.1. Introduction
20.9.1.2. Market Analysis and Forecast by Market Taxonomy
20.9.1.2.1. By Product
20.9.1.2.2. By Gender
20.9.1.2.3. By End User
20.9.2. Israel Contraceptives Market Analysis
20.9.2.1. Introduction
20.9.2.2. Market Analysis and Forecast by Market Taxonomy
20.9.2.2.1. By Product
20.9.2.2.2. By Gender
20.9.2.2.3. By End User
20.9.3. Turkey Contraceptives Market Analysis
20.9.3.1. Introduction
20.9.3.2. Market Analysis and Forecast by Market Taxonomy
20.9.3.2.1. By Product
20.9.3.2.2. By Gender
20.9.3.2.3. By End User
20.9.4. South Africa & North Africa Contraceptives Market Analysis
20.9.4.1. Introduction
20.9.4.2. Market Analysis and Forecast by Market Taxonomy
20.9.4.2.1. By Product
20.9.4.2.2. By Gender
20.9.4.2.3. By End User
20.9.5. Rest of MEA Contraceptives Market Analysis
20.9.5.1. Introduction
20.9.5.2. Market Analysis and Forecast by Market Taxonomy
20.9.5.2.1. By Product
20.9.5.2.2. By Gender
20.9.5.2.3. By End User
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Presence Analysis
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive
22.3.1. Bayer AG Pfizer Inc.
22.3.1.1. Overview
22.3.1.2. Product Portfolio
22.3.1.3. SWOT Analysis
22.3.1.4. Sales Footprint
22.3.1.5. Strategy Overview
22.3.1.6. Key financials
22.3.2. Janssen Global Product, LLC
22.3.2.1. Overview
22.3.2.2. Product Portfolio
22.3.2.3. SWOT Analysis
22.3.2.4. Sales Footprint
22.3.2.5. Strategy Overview
22.3.2.6. Key financials
22.3.3. Teva Pharmaceutical Industries Ltd.
22.3.3.1. Overview
22.3.3.2. Product Portfolio
22.3.3.3. SWOT Analysis
22.3.3.4. Sales Footprint
22.3.3.5. Strategy Overview
22.3.3.6. Key financials
22.3.4. Merck & Co., Inc.
22.3.4.1. Overview
22.3.4.2. Product Portfolio
22.3.4.3. SWOT Analysis
22.3.4.4. Sales Footprint
22.3.4.5. Strategy Overview
22.3.4.6. Key financials
22.3.5. Mylan N.V.
22.3.5.1. Overview
22.3.5.2. Product Portfolio
22.3.5.3. SWOT Analysis
22.3.5.4. Sales Footprint
22.3.5.5. Strategy Overview
22.3.5.6. Key financials
22.3.6. Allergan Plc.
22.3.6.1. Overview
22.3.6.2. Product Portfolio
22.3.6.3. SWOT Analysis
22.3.6.4. Sales Footprint
22.3.6.5. Strategy Overview
22.3.6.6. Key financials
22.3.7. Reckitt Benckiser Group plc.
22.3.7.1. Overview
22.3.7.2. Product Portfolio
22.3.7.3. SWOT Analysis
22.3.7.4. Sales Footprint
22.3.7.5. Strategy Overview
22.3.7.6. Key financials
22.3.8. Veru Inc.
22.3.8.1. Overview
22.3.8.2. Product Portfolio
22.3.8.3. SWOT Analysis
22.3.8.4. Sales Footprint
22.3.8.5. Strategy Overview
22.3.8.6. Key financials
22.3.9. Church & Dwight Co., Inc.
22.3.9.1. Overview
22.3.9.2. Product Portfolio
22.3.9.3. SWOT Analysis
22.3.9.4. Sales Footprint
22.3.9.5. Strategy Overview
22.3.9.6. Key financials
22.3.10. Medisafe Distribution Inc.
22.3.10.1. Overview
22.3.10.2. Product Portfolio
22.3.10.3. SWOT Analysis
22.3.10.4. Sales Footprint
22.3.10.5. Strategy Overview
22.3.10.6. Key financials
22.3.11. Cooper Surgical, Inc.
22.3.11.1. Overview
22.3.11.2. Product Portfolio
22.3.11.3. SWOT Analysis
22.3.11.4. Sales Footprint
22.3.11.5. Strategy Overview
22.3.11.6. Key financials
22.3.12. Mayer Laboratories, Inc.
22.3.12.1. Overview
22.3.12.2. Product Portfolio
22.3.12.3. SWOT Analysis
22.3.12.4. Sales Footprint
22.3.12.5. Strategy Overview
22.3.12.6. Key financials
22.3.13. Pfizer Inc.
22.3.13.1. Overview
22.3.13.2. Product Portfolio
22.3.13.3. SWOT Analysis
22.3.13.4. Sales Footprint
22.3.13.5. Strategy Overview
22.3.13.6. Key financials
22.3.14. The Female Health Company
22.3.14.1. Overview
22.3.14.2. Product Portfolio
22.3.14.3. SWOT Analysis
22.3.14.4. Sales Footprint
22.3.14.5. Strategy Overview
22.3.14.6. Key financials
22.3.15. Exeltis USA, Inc.
22.3.15.1. Overview
22.3.15.2. Product Portfolio
22.3.15.3. SWOT Analysis
22.3.15.4. Sales Footprint
22.3.15.5. Strategy Overview
22.3.15.6. Key financials
23. Assumptions and Acronyms Used
24. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Contraceptives Market Volume (Units) Analysis 2017–2021 and Forecast, 2022–2032, by Product
Table 02: Global Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Product
Table 03: Global Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Gender
Table 04: Global Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by End User
Table 05: Global Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Region
Table 06: North America Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Country
Table 07: North America Contraceptives Market Volume (Units) Analysis 2017–2021 and Forecast, 2022–2032, by Product
Table 08: North America Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Product
Table 09: North America Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Gender
Table 10: North America Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by End User
Table 11: Latin America Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Country
Table 12: Latin America Contraceptives Market Volume (Units) Analysis 2017–2021 and Forecast, 2022–2032, by Product
Table 13: Latin America Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Product
Table 14: Latin America Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Gender
Table 15: Latin America Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by End User
Table 16: Europe Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Country
Table 17: Europe Contraceptives Market Volume (Units) Analysis 2017–2021 and Forecast, 2022–2032, by Product
Table 18: Europe Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Product
Table 19: Europe Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Gender
Table 20: Europe Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by End User
Table 21: South Asia Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Country
Table 22: South Asia Contraceptives Market Volume (Units) Analysis 2017–2021 and Forecast, 2022–2032, by Product
Table 23: South Asia Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Product
Table 24: South Asia Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Gender
Table 25: South Asia Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by End User
Table 26: East Asia Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Country
Table 27: East Asia Contraceptives Market Volume (Units) Analysis 2017–2021 and Forecast, 2022–2032, by Product
Table 28: East Asia Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Product
Table 29: East Asia Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Gender
Table 30: East Asia Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by End User
Table 31: Oceania Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Country
Table 32: Oceania Contraceptives Market Volume (Units) Analysis 2017–2021 and Forecast, 2022–2032, by Product
Table 33: Oceania Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Product
Table 34: Oceania Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Gender
Table 35: Oceania Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by End User
Table 36: MEA Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Country
Table 37: MEA Contraceptives Market Volume (Units) Analysis 2017–2021 and Forecast, 2022–2032, by Product
Table 38: MEA Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Product
Table 39: MEA Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Gender
Table 40: MEA Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by End User
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Contraceptives Market Volume (in Units) Analysis, 2017–2021
Figure 02: Global Contraceptives Market Volume (in Units) & Y-o-Y Growth (%) Forecast, 2022–2032
Figure 03: Global Average Pricing Analysis Benchmark US$ per unit (2021)
Figure 04: Mini Devices Pricing Analysis (US$) for Per Unit, by Country, 2021
Figure 05: Cone Devices Pricing Analysis (US$) for Per Unit, by Country, 2021
Figure 06: Balloon Catheter Devices Pricing Analysis (US$) for Per Unit, by Country, 2021
Figure 07: Bed Systems Pricing Analysis (US$) for Per Unit, by Country, 2021
Figure 08: Global Contraceptives Market Size (‘US$ Mn) Analysis, 2017–2021
Figure 09: Global Contraceptives Market Size (US$ Mn)) & Y-o-Y Growth (%) Forecast, 2022–2032
Figure 10: Global Contraceptives Market Absolute $ Opportunity Analysis, 2022–2032
Figure 11: Global Contraceptives Market Analysis by Product–2022 & 2032
Figure 12: Global Contraceptives Market Y-o-Y Growth Projections by Product, 2022 – 2032
Figure 13: Global Contraceptives Market Attractiveness Analysis, by Product, 2022-2032
Figure 14: Global Contraceptives Market Analysis by Gender –2022 & 2032
Figure 15: Global Contraceptives Market Y-o-Y Growth Projections by Gender, 2022 – 2032
Figure 16: Global Contraceptives Market Attractiveness Analysis, by Gender, 2022-2032
Figure 17: Global Contraceptives Market Analysis by End User –2022 & 2032
Figure 18: Global Contraceptives Market Y-o-Y Growth Projections by End User, 2022 – 2032
Figure 19: Global Contraceptives Market Attractiveness Analysis, by End User, 2022-2032
Figure 20: Global Contraceptives Market Analysis by Region –2022 & 2032
Figure 21: Global Contraceptives Market Y-o-Y Growth Projections by Region, 2022 – 2032
Figure 22: Global Contraceptives Market Attractiveness Analysis, by Region, 2022-2032
Figure 23: North America Contraceptives Market Value Share, by Country (2022 E)
Figure 24: North America Contraceptives Market Value Share, by Product (2022 E)
Figure 25: North America Contraceptives Market Value Share, by Gender (2022 E)
Figure 26: North America Contraceptives Market Value Share, by End User (2022 E)
Figure 27: North America Contraceptives Market Size (‘US$ Mn) Analysis, 2017–2021
Figure 28: North America Contraceptives Market Size (US$ Mn)) & Y-o-Y Growth (%) Forecast, 2022–2032
Figure 29: North America Contraceptives Market Attractiveness Analysis 2022-2032, by Country
Figure 30: North America Contraceptives Market Attractiveness Analysis 2022-2032, by Product
Figure 31: North America Contraceptives Market Attractiveness Analysis 2022-2032, by Gender
Figure 32: North America Contraceptives Market Attractiveness Analysis 2022-2032, by End User
Figure 33: Latin America Contraceptives Market Value Share, by Country (2022 E)
Figure 34: Latin America Contraceptives Market Value Share, by Product (2022 E)
Figure 35: Latin America Contraceptives Market Value Share, by Gender (2022 E)
Figure 36: Latin America Contraceptives Market Value Share, by End User (2022 E)
Figure 37: Latin America Contraceptives Market Size (‘US$ Mn) Analysis, 2017–2021
Figure 38: Latin America Contraceptives Market Size (US$ Mn)) & Y-o-Y Growth (%) Forecast, 2022–2032
Figure 39: Latin America Contraceptives Market Attractiveness Analysis 2022-2032, by Country
Figure 40: Latin America Contraceptives Market Attractiveness Analysis 2022-2032, by Product
Figure 41: Latin America Contraceptives Market Attractiveness Analysis 2022-2032, by Gender
Figure 42: Latin America Contraceptives Market Attractiveness Analysis 2022-2032, by End User
Figure 43: Europe Contraceptives Market Value Share, by Country (2022 E)
Figure 44: Europe Contraceptives Market Value Share, by Product (2022 E)
Figure 45: Europe Contraceptives Market Value Share, by Gender (2022 E)
Figure 46: Europe Contraceptives Market Value Share, by End User (2022 E)
Figure 47: Europe Contraceptives Market Size (‘US$ Mn) Analysis, 2017–2021
Figure 48: Europe Contraceptives Market Size (US$ Mn)) & Y-o-Y Growth (%) Forecast, 2022–2032
Figure 49: Europe Contraceptives Market Attractiveness Analysis 2022-2032, by Country
Figure 50: Europe Contraceptives Market Attractiveness Analysis 2022-2032, by Product
Figure 51: Europe Contraceptives Market Attractiveness Analysis 2022-2032, by Gender
Figure 52: Europe Contraceptives Market Attractiveness Analysis 2022-2032, by End User
Figure 53: South Asia Contraceptives Market Value Share, by Country (2022 E)
Figure 54: South Asia Contraceptives Market Value Share, by Product (2022 E)
Figure 55: South Asia Contraceptives Market Value Share, by Gender (2022 E)
Figure 56: South Asia Contraceptives Market Value Share, by End User (2022 E)
Figure 57: South Asia Contraceptives Market Size (‘US$ Mn) Analysis, 2017–2021
Figure 58: South Asia Contraceptives Market Size (US$ Mn)) & Y-o-Y Growth (%) Forecast, 2022–2032
Figure 59: South Asia Contraceptives Market Attractiveness Analysis 2022-2032, by Country
Figure 60: South Asia Contraceptives Market Attractiveness Analysis 2022-2032, by Product
Figure 61: South Asia Contraceptives Market Attractiveness Analysis 2022-2032, by Gender
Figure 62: South Asia Contraceptives Market Attractiveness Analysis 2022-2032, by End User
Figure 63: East Asia Contraceptives Market Value Share, by Country (2022 E)
Figure 64: East Asia Contraceptives Market Value Share, by Product (2022 E)
Figure 65: East Asia Contraceptives Market Value Share, by Gender (2022 E)
Figure 66: East Asia Contraceptives Market Value Share, by End User (2022 E)
Figure 67: East Asia Contraceptives Market Size (‘US$ Mn) Analysis, 2017–2021
Figure 68: East Asia Contraceptives Market Size (US$ Mn)) & Y-o-Y Growth (%) Forecast, 2022–2032
Figure 69: East Asia Contraceptives Market Attractiveness Analysis 2022-2032, by Country
Figure 70: East Asia Contraceptives Market Attractiveness Analysis 2022-2032, by Product
Figure 71: East Asia Contraceptives Market Attractiveness Analysis 2022-2032, by Gender
Figure 72: East Asia Contraceptives Market Attractiveness Analysis 2022-2032, by End User
Figure 73: Oceania Contraceptives Market Value Share, by Country (2022 E)
Figure 74: Oceania Contraceptives Market Value Share, by Product (2022 E)
Figure 75: Oceania Contraceptives Market Value Share, by Gender (2022 E)
Figure 76: Oceania Contraceptives Market Value Share, by End User (2022 E)
Figure 77: Oceania Contraceptives Market Size (‘US$ Mn) Analysis, 2017–2021
Figure 78: Oceania Contraceptives Market Size (US$ Mn)) & Y-o-Y Growth (%) Forecast, 2022–2032
Figure 79: Oceania Contraceptives Market Attractiveness Analysis 2022-2032, by Country
Figure 80: Oceania Contraceptives Market Attractiveness Analysis 2022-2032, by Product
Figure 81: Oceania Contraceptives Market Attractiveness Analysis 2022-2032, by Gender
Figure 82: Oceania Contraceptives Market Attractiveness Analysis 2022-2032, by End User
Figure 83: MEA Contraceptives Market Value Share, by Country (2022 E)
Figure 84: MEA Contraceptives Market Value Share, by Product (2022 E)
Figure 85: MEA Contraceptives Market Value Share, by Gender (2022 E)
Figure 86: MEA Contraceptives Market Value Share, by End User (2022 E)
Figure 87: MEA Contraceptives Market Size (US$ Mn) Analysis, 2017–2021
Figure 88: MEA Contraceptives Market Size (US$ Mn) & Y-o-Y Growth (%) Forecast, 2022–2032
Figure 89: MEA Contraceptives Market Attractiveness Analysis 2022-2032, by Country
Figure 90: MEA Contraceptives Market Attractiveness Analysis 2022-2032, by Product
Figure 91: MEA Contraceptives Market Attractiveness Analysis 2022-2032, by Gender
Figure 92: MEA Contraceptives Market Attractiveness Analysis 2022-2032, by End User
Figure 93: Global Contraceptives Market Value Proportion Analysis, by Countries, 2021
Figure 94: Global Contraceptives Market, Global Vs. Country Growth Y-o-Y (%) Comparison, 2022-2032
Figure 95: U.S. Contraceptives Market Share Analysis (%) by Product, 2022 & 2032
Figure 96: U.S. Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032
Figure 97: U.S. Contraceptives Market Share Analysis (%) by End User, 2022 & 2032
Figure 98: Canada Contraceptives Market Share Analysis (%) by Product, 2022 & 2032
Figure 99: Canada Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032
Figure 100: Canada Contraceptives Market Share Analysis (%) by End User, 2022 & 2032
Figure 101: Brazil Contraceptives Market Share Analysis (%) by Product, 2022 & 2032
Figure 102: Brazil Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032
Figure 103: Brazil Contraceptives Market Share Analysis (%) by End User, 2022 & 2032
Figure 104: Mexico Contraceptives Market Share Analysis (%) by Product, 2022 & 2032
Figure 105: Mexico Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032
Figure 106: Mexico Contraceptives Market Share Analysis (%) by End User, 2022 & 2032
Figure 107: Argentina Contraceptives Market Share Analysis (%) by Product, 2022 & 2032
Figure 108: Argentina Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032
Figure 109: Argentina Contraceptives Market Share Analysis (%) by End User, 2022 & 2032
Figure 110: Germany Contraceptives Market Share Analysis (%) by Product, 2022 & 2032
Figure 111: Germany Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032
Figure 112: Germany Contraceptives Market Share Analysis (%) by End User, 2022 & 2032
Figure 113: Italy Contraceptives Market Share Analysis (%) by Product, 2022 & 2032
Figure 114: Italy Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032
Figure 115: Italy Contraceptives Market Share Analysis (%) by End User, 2022 & 2032
Figure 116: France Contraceptives Market Share Analysis (%) by Product, 2022 & 2032
Figure 117: France Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032
Figure 118: France Contraceptives Market Share Analysis (%) by End User, 2022 & 2032
Figure 119: U.K. Contraceptives Market Share Analysis (%) by Product, 2022 & 2032
Figure 120: U.K. Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032
Figure 121: U.K. Contraceptives Market Share Analysis (%) by End User, 2022 & 2032
Figure 122: Spain Contraceptives Market Share Analysis (%) by Product, 2022 & 2032
Figure 123: Spain Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032
Figure 124: Spain Contraceptives Market Share Analysis (%) by End User, 2022 & 2032
Figure 125: BENELUX Contraceptives Market Share Analysis (%) by Product, 2022 & 2032
Figure 126: BENELUX Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032
Figure 127: BENELUX Contraceptives Market Share Analysis (%) by End User, 2022 & 2032
Figure 128: Russia Contraceptives Market Share Analysis (%) by Product, 2022 & 2032
Figure 129: Russia Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032
Figure 130: Russia Contraceptives Market Share Analysis (%) by End User, 2022 & 2032
Figure 131: India Contraceptives Market Share Analysis (%) by Product, 2022 & 2032
Figure 132: India Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032
Figure 133: India Contraceptives Market Share Analysis (%) by End User, 2022 & 2032
Figure 134: Thailand Contraceptives Market Share Analysis (%) by Product, 2022 & 2032
Figure 135: Thailand Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032
Figure 136: Thailand Contraceptives Market Share Analysis (%) by End User, 2022 & 2032
Figure 137: Indonesia Contraceptives Market Share Analysis (%) by Product, 2022 & 2032
Figure 138: Indonesia Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032
Figure 139: Indonesia Contraceptives Market Share Analysis (%) by End User, 2022 & 2032
Figure 140: Malaysia Contraceptives Market Share Analysis (%) by Product, 2022 & 2032
Figure 141: Malaysia Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032
Figure 142: Malaysia Contraceptives Market Share Analysis (%) by End User, 2022 & 2032
Figure 143: China Contraceptives Market Share Analysis (%) by Product, 2022 & 2032
Figure 144: China Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032
Figure 145: China Contraceptives Market Share Analysis (%) by End User, 2022 & 2032
Figure 146: Japan Contraceptives Market Share Analysis (%) by Product, 2022 & 2032
Figure 147: Japan Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032
Figure 148: Japan Contraceptives Market Share Analysis (%) by End User, 2022 & 2032
Figure 149: South Korea Contraceptives Market Share Analysis (%) by Product, 2022 & 2032
Figure 150: South Korea Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032
Figure 151: South Korea Contraceptives Market Share Analysis (%) by End User, 2022 & 2032
Figure 152: Australia Contraceptives Market Share Analysis (%) by Product, 2022 & 2032
Figure 153: Australia Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032
Figure 154: Australia Contraceptives Market Share Analysis (%) by End User, 2022 & 2032
Figure 155: New Zealand Contraceptives Market Share Analysis (%) by Product, 2022 & 2032
Figure 156: New Zealand Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032
Figure 157: New Zealand Contraceptives Market Share Analysis (%) by End User, 2022 & 2032
Figure 158: GCC Countries Contraceptives Market Share Analysis (%) by Product, 2022 & 2032
Figure 159: GCC Countries Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032
Figure 160: GCC Countries Contraceptives Market Share Analysis (%) by End User, 2022 & 2032
Figure 161: Turkey Contraceptives Market Share Analysis (%) by Product, 2022 & 2032
Figure 162: Turkey Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032
Figure 163: Turkey Contraceptives Market Share Analysis (%) by End User, 2022 & 2032
Figure 164: South Africa Contraceptives Market Share Analysis (%) by Product, 2022 & 2032
Figure 165: South Africa Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032
Figure 166: South Africa Contraceptives Market Share Analysis (%) by End User, 2022 & 2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
